BPC-157 vs GHK-Cu
BPC-157 and GHK-Cu are both stocked here and are often considered together. This page sets out what differs between them: their class, the sizes and price per milligram, the shape of the published evidence behind each, and where each stands under Canadian law. It does not rank them, because which is appropriate depends on what is being studied.
Side by side
| BPC-157 | GHK-Cu | |
|---|---|---|
| Class | Synthetic pentadecapeptide derived from a gastric protein | Copper-binding tripeptide (Gly-His-Lys copper complex) |
| Sizes and price | 10 mg — from $52.00 (best $5.20/mg) | 50 mg · 100 mg — from $43.50 (best $0.62/mg) |
| Published evidence | 7 cited studies; 3 in people, none controlled. | 8 cited studies; 1 controlled trial in people. |
| Models studied | human, rat, enzyme assay in vitro | human, human skin in vitro, mouse |
| Status in Canada | No Drug Identification Number; named in a Health Canada advisory | No Drug Identification Number; named in a Health Canada advisory |
| Formats | vial, capsules, starter, value | vial, starter, value |
Key differences
BPC-157 7 cited studies; 3 in people, none controlled. GHK-Cu 8 cited studies; 1 controlled trial in people.
No published study has compared BPC-157 and GHK-Cu directly. Everything above is drawn from separate studies of each compound, so the two columns are not results from one experiment.
Both are supplied for in-vitro laboratory research only and neither is for human or veterinary use.
FAQ
What is the difference between BPC-157 and GHK-Cu?
BPC-157 is synthetic pentadecapeptide derived from a gastric protein; GHK-Cu is copper-binding tripeptide (gly-his-lys copper complex). The table above sets out the sizes, the price per milligram, the evidence behind each and their Canadian status.
Which has more published research, BPC-157 or GHK-Cu?
BPC-157 has 7 cited studies on its page and GHK-Cu has 8. Study count is not quality: the model each one used matters more, and both pages list that for every paper.
Are BPC-157 and GHK-Cu authorized in Canada?
No Drug Identification Number; named in a Health Canada advisory for BPC-157. No Drug Identification Number; named in a Health Canada advisory for GHK-Cu. Health Canada authorizes a drug by issuing an eight-digit Drug Identification Number, and most research peptides have none.
Can BPC-157 and GHK-Cu be used together?
No published study has tested them in combination, so there is no evidence about what a pairing does. We supply both for laboratory research and make no claim about using them together.